REBECCA WOLTMAN: Open Payments
NPI 1437609146 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 9 payments from 8 companies in 2025. Trend: 2023 $81 · 2024 $203 · 2025 $255
Food & beverage: $186Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| SOBI, INC | 1 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $27 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
| Incyte Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: IMFINZI, Vonjo, KISQALI, RYBREVANT, Tibsovo, JAKAFI, VERZENIO, Trodelvy.
Industry payments across MI — which companies pay providers there.
